In 2015, when the biotech where she had been chief medical officer for four years got scooped up by Celgene for about $7 billion, Dr. Sheila Gujrathi took a step back and thought about her next move.
A Stanford- and Harvard-trained physician, Gujrathi had …
Read More

Leave a Reply